# Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

> **NCT05584267** · PHASE2 · RECRUITING · sponsor: **Hunan Province Tumor Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **RADIATION:** radiotherapy
- **DRUG:** Chemotherapy + immunotherapy

## Key facts

- **NCT ID:** NCT05584267
- **Lead sponsor:** Hunan Province Tumor Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-25
- **Primary completion:** 2025-11-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584267, "Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05584267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*